NEW YORK, NY / ACCESS Newswire / December 29, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Freeport-McMoRan Inc. (NYSE:FCX) class action securities lawsuit A Class Action lawsuit was filed on behalf of Freeport-McMoRan Inc. investors who lost money as a result of alleged securities fraud between February 15, 2022 and September 24, […]

NEW YORK, NY / ACCESS Newswire / December 29, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Telix Pharmaceuticals Ltd. (NASDAQ:TLX) class action securities lawsuit A Class Action lawsuit was filed on behalf of Telix Pharmaceuticals Ltd. investors who lost money as a result of alleged securities fraud between February 21, 2025 and

(NASDAQ:HTOO), Deployment of up to EUR30 million of Partner-committed capital, to be released over time in three potential tranches of EUR10 million each. First project expected to be a green hydrogen production facility in Spain in 2026. Dublin, Ireland, Dec. 29, 2025 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (NASDAQ:HTOO) (“Fusion Fuel” or the “Company”),

(NASDAQ:TNXP), Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field study Expect to have investigational product of TNX-4800 (anti-Borrelia OspA mAb) available for clinical trials in early 2027 Approximately 70 million people that live, work or vacation in areas of the U.S. in which Lyme disease

Fusion Fuel's BrightHy Solutions Signs Agreements to Launch Up to EUR30 Million Targeted Hydrogen Investment Platform GlobeNewswire December 29, 2025 Deployment of up to EUR30 million of Partner-committed capital, to be released over time in three potential tranches of EUR10 million each. First project expected to be a green hydrogen production facility in Spain in

Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800) GlobeNewswire December 29, 2025 Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field study Expect to have investigational product of TNX-4800 (anti-Borrelia OspA mAb) available for

NEW YORK, NY / ACCESS Newswire / December 29, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Inspire Medical Systems, Inc. (NYSE:INSP) class action securities lawsuit A Class Action lawsuit was filed on behalf of Inspire Medical Systems, Inc. investors who lost money as a result of alleged securities fraud between August 6,

PANAMA CITY, Dec. 29, 2025 (GLOBE NEWSWIRE) — AZX, a next-generation decentralized exchange (DEX) built on the trading-optimized AZ Axis blockchain network, announced the launch of its Beta testing, introducing groundbreaking performance capabilities and innovative features designed to bridge the gap between traditional finance and decentralized trading. AZX represents a technological leap in decentralized trading

NEW YORK, NY / ACCESS Newswire / December 29, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding CarMax, Inc. (NYSE:KMX) class action securities lawsuit A Class Action lawsuit was filed on behalf of CarMax, Inc. investors who lost money as a result of alleged securities fraud between June 20, 2025 and November 5,

AZX, an Oder Book DEX, Debuts Beta Testing with Breakthrough Performance and Innovation GlobeNewswire December 29, 2025 PANAMA CITY, Dec. 29, 2025 (GLOBE NEWSWIRE) — AZX, a next-generation decentralized exchange (DEX) built on the trading-optimized AZ Axis blockchain network, announced the launch of its Beta testing, introducing groundbreaking performance capabilities and innovative features designed to